NASDAQ:ICCC

Immucell Stock Insider Trading

Healthcare > Biotechnology

Buy ICCC

*Your capital is at risk

$10.05

+0.260 (+2.66%)

At Close: Jun 03, 2026

ImmuCell Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 94.67. In total, the insiders bought 97.47M and sold 91.08K ICCC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	94.67
● Buy	97.47M shares
● Sell	91.08K shares
54% Buy Activity Strong Positive Correlation
Sell Signal Low Confidence Mar 20, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 94.67. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Sep 16, 2028 Buy	Non Qualified Stock Option (right to buy)	Te Boekhorst Paul Francis Olivier President And CEO	CEO / President	25 329 Value: $149.4K
Apr 15, 2026 Buy	Non Qualified Stock Options (Right to buy)	Dimarco Anthony Director	Director	17 899 Value: $136.0K
Apr 15, 2026 Buy	Non Qualified Stock Options (Right to buy)	Guillemette Gilles Director	Director	17 899 Value: $136.0K
Apr 15, 2026 Buy	Non Qualified Stock Options (Right to buy) A-Award	Turner Kathy V Director	Director	17 899 Value: $136.0K
Apr 15, 2026 Buy	Non Qualified Stock Options (Right to buy) A-Award	Tomsche David Scott Director	Director	11 933 Value: $90.7K
Apr 15, 2026 Buy	Non Qualified Stock Options (Right to buy) A-Award	Basse Gloria F Director	Director	11 933 Value: $90.7K
Apr 15, 2026 Buy	Non Qualified Stock Options (Right to buy) A-Award	Wainman Paul R Director	Director	11 933 Value: $90.7K
Apr 01, 2026 Buy	Common Stock J-Other	Turner Kathy V	Director	0 Value: $0
Mar 20, 2026 Buy	Common Stock, par value $.01 per share M-Exempt	Brigham Michael F Director	Director	25 000 Value: $146.0K
Mar 20, 2026 Sell	Common Stock, par value $.01 per share F-InKind	Brigham Michael F Director	Director	24 052 Value: $146.0K
Mar 20, 2026 Buy	Stock Options (right to buy) M-Exempt	Brigham Michael F Director	Director	25 000 Value: $146.0K
Jan 27, 2026 Buy	Stock Options (right to buy) A-Award	Te Boekhorst Paul Francis Olivier President And CEO	CEO / President	109 500 Value: $686.0K
Jan 27, 2026 Buy	Stock Options (right to buy) A-Award	Brockmann Bobbi Jo Vp Of Sales And Marketing	Officer	100 000 Value: $626.5K
Jan 27, 2026 Buy	Stock Options (right to buy) A-Award	Fiori Timothy C Chief Financial Officer	C-Suite Officer	120 000 Value: $751.8K
Jan 27, 2026 Buy	Stock Options (right to buy) A-Award	Te Boekhorst Paul Francis Olivier President And CEO	CEO / President	110 000 Value: $689.2K
Dec 04, 2025 Buy	Common Stock $0.10 par value per share P-Purchase	Te Boekhorst Paul Francis Olivier President And CEO	CEO / President	2 432 Value: $13.4K
Dec 03, 2025 Buy	Common Stock $0.10 par value per share P-Purchase	Te Boekhorst Paul Francis Olivier President And CEO	CEO / President	3 598 Value: $18.2K
Dec 03, 2025 Buy	Common Stock $0.10 par value per share P-Purchase	Te Boekhorst Paul Francis Olivier President And CEO	CEO / President	2 556 Value: $12.8K
Dec 03, 2025 Buy	Common Stock $0.10 par value per share P-Purchase	Te Boekhorst Paul Francis Olivier President And CEO	CEO / President	3 521 Value: $17.7K
Dec 02, 2025 Buy	Common Stock $0.10 par value per share P-Purchase	Te Boekhorst Paul Francis Olivier President And CEO	CEO / President	3 708 Value: $18.1K
Nov 25, 2025 Buy	Common Stock $0.10 par value per share P-Purchase	Tomsche David Scott Director	Director	1 633 Value: $8K
Nov 25, 2025 Buy	Common Stock $0.10 par value per share P-Purchase	Tomsche David Scott Director	Director	1 633 Value: $8K
Nov 07, 2025 Buy	Stock Options (right to buy) A-Award	Te Boekhorst Paul Francis Olivier President And CEO	CEO / President	74 277 Value: $453.1K
Jun 12, 2025 Buy	Common stock $0.10 per value per share P-Purchase	Gathagan Bryan K. Director	Director	1 000 Value: $6K
Jun 12, 2025 Buy	Common stock $0.10 per value per share P-Purchase	Gathagan Bryan K. Director	Director	1 000 Value: $6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT IMMUCELL CORPORATION

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides Ca...

Read Full Profile Here